Brief: Hyperfine Announces Enrollment Of First Patient In Study To Expand Intended Use Of The Swoop® System With Contrast Agents
15/01/2026 13:17
Jan 15 (Reuters) - Hyperfine Inc HYPR.O: HYPERFINE ANNOUNCES ENROLLMENT OF FIRST PATIENT IN STUDY TO EXPAND INTENDED USE OF THE SWOOP® SYSTEM WITH CONTRAST AGENTS Source text: ID:nBw4hpNWKa Further company coverage: HYPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperfine
See all newsPortable MRI maker Hyperfine's Q3 prelim revenue beats estimates; FY outlook reaffirmed
Brief: Hyperfine, Inc. Q3 Sales USD 6 Million
Hyperfine Inc reports results for the quarter ended June 30 - Earnings Summary
Portable MRI maker Hyperfine's Q2 revenue rises less than expected
Brief: Hyperfine, Inc. Q2 EPS USD -0.09